109 related articles for article (PubMed ID: 11586108)
1. In vivo proton (H1) magnetic resonance spectroscopy for cervical carcinoma.
Allen JR; Prost RW; Griffith OW; Erickson SJ; Erickson BA
Am J Clin Oncol; 2001 Oct; 24(5):522-9. PubMed ID: 11586108
[TBL] [Abstract][Full Text] [Related]
2. 1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration.
Mahon MM; Williams AD; Soutter WP; Cox IJ; McIndoe GA; Coutts GA; Dina R; deSouza NM
NMR Biomed; 2004 Feb; 17(1):1-9. PubMed ID: 15011245
[TBL] [Abstract][Full Text] [Related]
3. (1)H magnetic resonance spectroscopy of preinvasive and invasive cervical cancer: in vivo-ex vivo profiles and effect of tumor load.
Mahon MM; Cox IJ; Dina R; Soutter WP; McIndoe GA; Williams AD; deSouza NM
J Magn Reson Imaging; 2004 Mar; 19(3):356-64. PubMed ID: 14994305
[TBL] [Abstract][Full Text] [Related]
4. Preinvasive and invasive cervical cancer: an ex vivo proton magic angle spinning magnetic resonance spectroscopy study.
Mahon MM; deSouza NM; Dina R; Soutter WP; McIndoe GA; Williams AD; Cox IJ
NMR Biomed; 2004 May; 17(3):144-53. PubMed ID: 15137039
[TBL] [Abstract][Full Text] [Related]
5. Proton MR and human cervical neoplasia: ex vivo spectroscopy allows distinction of invasive carcinoma of the cervix from carcinoma in situ and other preinvasive lesions.
Delikatny EJ; Russell P; Hunter JC; Hancock R; Atkinson KH; van Haaften-Day C; Mountford CE
Radiology; 1993 Sep; 188(3):791-6. PubMed ID: 8351349
[TBL] [Abstract][Full Text] [Related]
6. Detection of cancer in cervical tissue biopsies using mobile lipid resonances measured with diffusion-weighted (1)H magnetic resonance spectroscopy.
Zietkowski D; Davidson RL; Eykyn TR; De Silva SS; Desouza NM; Payne GS
NMR Biomed; 2010 May; 23(4):382-90. PubMed ID: 20014336
[TBL] [Abstract][Full Text] [Related]
7. In vivo magnetic resonance spectroscopy of gynaecological tumours at 3.0 Tesla.
Booth SJ; Pickles MD; Turnbull LW
BJOG; 2009 Jan; 116(2):300-3. PubMed ID: 19076962
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma.
Mun CW; Cho JY; Shin WJ; Choi KS; Eun CK; Cha SS; Lee J; Yang YI; Nam SH; Kim J; Lee SY
Magn Reson Imaging; 2004 Jul; 22(6):861-70. PubMed ID: 15234456
[TBL] [Abstract][Full Text] [Related]
9. Human cancers detected by proton MRS and chemical shift imaging ex vivo.
Mountford CE; Mackinnon WB; Russell P; Rutter A; Delikatny EJ
Anticancer Res; 1996; 16(3B):1521-31. PubMed ID: 8694521
[TBL] [Abstract][Full Text] [Related]
10. Proton magnetic resonance spectroscopy with a body coil in the diagnosis of carcinoma prostate.
Kumar R; Kumar M; Jagannathan NR; Gupta NP; Hemal AK
Urol Res; 2004 Feb; 32(1):36-40. PubMed ID: 14534764
[TBL] [Abstract][Full Text] [Related]
11. Synchronous endometrial and cervical tumors in a 26-year-old nullipara: diagnostic modalities updated.
Hascalik S; Celik O; Erdem G; Usta U; Alkan A; Karakas HM; Mizrak B
Gynecol Obstet Invest; 2005; 60(3):171-6. PubMed ID: 15995344
[TBL] [Abstract][Full Text] [Related]
12. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
[TBL] [Abstract][Full Text] [Related]
13. Investigation of metabolite changes in the transition from pre-invasive to invasive cervical cancer measured using (1)H and (31)P magic angle spinning MRS of intact tissue.
De Silva SS; Payne GS; Thomas V; Carter PG; Ind TE; deSouza NM
NMR Biomed; 2009 Feb; 22(2):191-8. PubMed ID: 18833545
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of mobile lipid resonances in tissue biopsies from patients with cervical cancer and correlation with cytoplasmic lipid droplets.
Zietkowski D; deSouza NM; Davidson RL; Payne GS
NMR Biomed; 2013 Sep; 26(9):1096-102. PubMed ID: 23417787
[TBL] [Abstract][Full Text] [Related]
15.
Lin G; Lai CH; Tsai SY; Lin YC; Huang YT; Wu RC; Yang LY; Lu HY; Chao A; Wang CC; Ng KK; Ng SH; Chou HH; Yen TC; Hung JH
J Magn Reson Imaging; 2017 Mar; 45(3):899-907. PubMed ID: 27434095
[TBL] [Abstract][Full Text] [Related]
16. Proton MRS of cervical cancer at 7 T.
Arteaga de Castro CS; Hoogendam JP; van Kalleveen IML; Raaijmakers AJE; Zweemer RP; Verheijen RHM; Luijten PR; Veldhuis WB; Klomp DWJ
NMR Biomed; 2019 Jan; 32(1):e4015. PubMed ID: 30376201
[TBL] [Abstract][Full Text] [Related]
17. The contribution of the
Dolciami M; Canese R; Testa C; Pernazza A; Santangelo G; Palaia I; Rocca CD; Catalano C; Manganaro L
Eur Radiol Exp; 2022 Oct; 6(1):47. PubMed ID: 36184731
[TBL] [Abstract][Full Text] [Related]
18. [In vivo proton MR spectroscopy of normal liver parenchyma: technique and results].
Müller C; Hübner F; Bisdas S; Herzog C; Hammerstingl RM; Ackermann H; Vorbuchner M; Vogl TJ
Rofo; 2006 Nov; 178(11):1128-36. PubMed ID: 17128381
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of ovarian tumors by proton magnetic resonance spectroscopy at three Tesla.
Stanwell P; Russell P; Carter J; Pather S; Heintze S; Mountford C
Invest Radiol; 2008 Oct; 43(10):745-51. PubMed ID: 18791417
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of proton MR spectroscopy in peripheral arterial occlusive disease: a prospective evaluation.
Stueckle CA; Claeys L; Haegele K; Zimmermann S; Mruck S; Adams S; Liermann D
AJR Am J Roentgenol; 2006 Nov; 187(5):1322-6. PubMed ID: 17056923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
